Ass. Prof. Dr. Karl Matz
Wissenschaftlicher Mitarbeiter - Zentrum für Vaskuläre Prävention
- karl.matz@donau-uni.ac.at
- +43 2732 893-2631
- +43 (0)2272 601-79757
- Zum Kontaktformular
- Campus Krems, Trakt I, EG, 0.315
- Donau-Universität Krems
- Zentrum für Vaskuläre Prävention
- Dr.-Karl-Dorrek-Straße 30
- 3500 Krems
- Österreich
Projekte (Auszug Forschungsdatenbank)
Publikationen (Auszug Forschungsdatenbank)
Matz, K. (2020). TEE, too hard to swallow? European Journal of Neurology, 28/1: 1-2, Wiley
Matz, K.; Tuomilehto, J.; Teuschl, Y.; Dachenhausen, A.; Brainin, M. (2020). Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke. Cardiovascular Diabetology, 19(1): 204, Springer Nature
Matz, K.; Tuomilehto, J.; Teuschl, Y.; Dachenhausen, A.; Brainin, M. (2020). Comparison of oral glucose tolerance test and HbA1c in detection of disorders of glucose metabolism in patients with acute stroke. Cardiovascular Diabetology, 19: https://doi.org/10.1186/s12933-020-01182-6
Ntaios, G.; Michel, P.; Georgiopoulos, G.; et al. (2020). Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry. Stroke, 2020 Sep;51(9): e254-e258, Lippincott
Teuschl, Y.; Matz, K.; Dachenhausen, A.; Brainin, M. (2020). Impaired glucose metabolism and cognitive performance after mild stroke.
ASPIS Study Group (2018). Multidomain intervention for the prevention of cognitive decline after stroke - a pooled patient-level data analysis. Eur J Neurol., 25: 1182-1188
Brainin, M.; Feigin, V.; Martins, S.; Matz, K.; Roy, J.; Sandercock, P.; Teuschl, Y.; Tuomilehto, J.; Wiseman, A. (2018). Cut stroke in half: Polypill for primary prevention in stroke. Int J Stroke, 25: 633-647
Matz, K. (2018). Frühe Thrombolyse von Schlaganfällen. neurologisch, 03: 87
Teuschl, Y.; Trapl, M:, Ratajczak, P.; Matz, K.; Dachenhausen, A.; Brainin, M. (2018). Systematic dysphagia screening and dietary modifications to reduce stroke-associated pneumonia rates in a stroke-unit. PLoS One, :e0192142: 10.1007/s00415-017-8720-8.
Mijajlovic, M.D.; Pavlovic, A.; Brainin, M.; Heiss, W.D.; Quinn, T.J.; Ihle-Hansen, H.B.; Hermann, D.M.; Assayag, E.B.; Richard, E.; Thiel, A.; Kliper, E.; Shin, Y.I.; Kim, Y.H.; Choi, S.; Jung, S.; Lee, Y.B.; Sinanovic, O.; Levine, D.A.; Schlesinger, I.; Mead, G.; Miloševic, V.; Leys, D.; Hagberg, G.; Ursin, M.H.; Teuschl, Y.; Prokopenko, S.; Mozheyko, E.; Bezdenezhnykh, A.; Matz, K.; et al. (2017). Post-stroke Dementia - a comprehensive review. BMC Medicine, 15(1):11: doi: 10.1186/s12916-017-0779-7
Teuschl, Y.; Matz, K.; Firlinger, B.; Dachenhausen, A.; Tuomilehto, J.; Brainin, M.; ASPIS Study Group. (2017). Preventive effects of multiple domain interventions on lifestyle and risk factor changes in stroke survivors: Evidence from a two-year randomized trial. International Journal of Stroke, 12(9): 976-984
Trapl, M.; Teuschl, Y.; Matz, K.; Dachenhausen, A.; Brainin, M. (2017). Overestimating the risk of aspiration in acute stroke. European Journal of Neurology, 24(6): doi:10.1111/ene.13298
Brainin, M.; Matz, K.; Nemec, M.; Teuschl, Y.; Dachenhausen, A.; Asenbaum-Nan, S.; Bancher, C.; Kepplinger B.; Oberndorfer, S.; Pinter, M.;, Schnider, P.; Tuomilehto, J.; ASPIS StudyGroup (2015). Prevention of poststroke cognitive decline: ASPIS - a multicenter,randomized, observer-blind, parallel group clinical trial to evaluate multiplelifestyle interventions - study design and baseline characteristics. International Journal of Stroke, 10(4): 627-35
Matz K.; Teuschl, Y.; Firlinger, B.; Dachenhausen, A.; Keindl, M.; Seyfang, L.; Tuomilehto, J.; Brainin, M. (2015). Multidomain Lifestyle Interventions for the Prevention of Cognitive Decline After Ischemic Stroke Randomized Trial. Stroke, 46(10): 2874-80
IST-3 collaborative group (2013). Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International StrokeTrial [IST-3]): 18-month follow-up of a randomised controlled trial. Lancet Neurol, 12(8): 768-76
Matz, K.; Brainin, M. (2013). Use of Intravenous recombinant tissue plasminogen activator in patients outside the defined criteria: safety and feasibility issues. Expert Rev Neurother, 13(2): 177-185
Teuschl, Y.; Brainin, M.; Matz, K.; Ferrari, J.; Lang, W. (2013). Time-trends in patient characteristics treated upon acute stroke units: Results from the Austrian Stroke Unit Registry 2003 – 2011. Stroke, 44(4): 1070-4
Teuschl, Y.; Matz, K.; Brainin, M. (2013). Prevention of post-stroke cognitive decline: a review focusing on lifestyle interventions. Eur J Neurol. 2013, 20(1): 35-49
IST-3 collaborative group (u.a. Brainin, M.), Sandercock, P.; Wardlaw, J.M.; Lindley, R.I.; Dennis, M.; Cohen, G.; Murray, G.; Innes, K.; Venables, G.; Czlonkowska, A.; Kobayashi, A.; Ricci, S.; Murray, V.; Berge, E.; Slot, K.B.; Hankey, G.J.; Correia, M.; Peeters, A.; Matz, K.; Lyrer, P.; Gubitz, G.; Phillips, S.J.; Arauz, A. (2012). The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet, 379(9834): 2352-63
Reiter, M.; Brainin, M.; Teuschl, Y.; Matz, K.; Seyfang, L.; Reindl, B. (2012). Thrombolysis in diabetic stroke patients: Results from the Austrian Stroke Unit Registry. Cerebrovasc Dis, 33 Suppl 2: 614-5
Vorträge (Auszug Forschungsdatenbank)
Life Style oriented Interventions and Prevention of Vascular and Non-vascular Cognitive Decline
1st Krems Dementia Conference 2019, Krems, Österreich, 06.11.2019
Organizing Stroke Care
European Academy of Neurology Spring School 2019, 04.06.2019
Prognoseabschätzung beim hypoxischen Koma nach CPR
Fortbildung Landesklinikum Tulln, Austria, 20.11.2013
Therapie und Prophylaxe des ischämischen Schlaganfalls - Was gibt es Neues?
Kurie der niedergelassenen Neurologinnen und Neurologen , Tulln, Austria, 10.10.2013
Off Label Thrombolyse.
Fortbildung Landesklinikum Tulln, Austria, 30.03.2013
Häufige Fragestellungen an das elektroneurodiagnostische Labor – Standards
Fortbildung Landesklinikum Tulln, 13.01.2013
Time-trends in patient characteristics treate upon acute stroke units: Results from the Austrian Stroke Unit Registry 2003 and 2011
8th World Stroke Congress, Brasilia, Brazil, 11.10.2012
Thrombolysis in diabetic stroke patients: Results from the Austrian Stroke Unit Registry
XXI European Stroke Conference, Lissabon, Portugal, 27.05.2012
Diabetes und Thrombolyse
15. Jahrestagung der ÖGSF, Innsbruck, Austria, 27.01.2012
IST 3 Trial - erste Zwischenergebnisse
15. Jahrestagung der ÖGSF, Innsbruck, Austria, 27.01.2012
IST 3 - erste Auswertung der Baseline-Daten
15. Jahrestagung der ÖGSF, Innsbruck, Austria, 27.01.2012
Diabetestherapie an der Stroke Unit
15. Jahrestagung der ÖGSF, Innsbruck, Austria, 26.01.2012
10 Risk factors for post stroke pneunomia in patients treated in stroke units - Austrian Stroke Unit Registry
20th European Stroke Conference, Hamburg, Germany, 26.05.2011
Tags